Search

Sami A Hashim

from Dobbs Ferry, NY
Age ~95

Sami Hashim Phones & Addresses

  • 42 Southlawn Ave, Dobbs Ferry, NY 10522 (914) 693-6040
  • Brooklyn, NY
  • Boca Raton, FL
  • New York, NY

Education

School / High School: State University of New York At Buffalo 1955

Languages

English

Specialities

Internal Medicine

Professional Records

Medicine Doctors

Sami Hashim Photo 1

Dr. Sami A Hashim, Dobbs Ferry NY - MD (Doctor of Medicine)

View page
Specialties:
Internal Medicine
Address:
42 Southlawn Ave, Dobbs Ferry, NY 10522
(914) 693-6040 (Phone), (914) 693-8349 (Fax)
Languages:
English
Education:
Medical School
State University of New York At Buffalo
Graduated: 1955
Sami Hashim Photo 2

Sami A Hashim

View page
Specialties:
Internal Medicine
Endocrinology, Diabetes & Metabolism
Education:
State University of New York at Buffalo (1955)

Business Records

Name / Title
Company / Classification
Phones & Addresses
Sami A. Hashim
Medical Doctor
St Luke's-Roosevelt Hospital Center
Medical Doctor's Office · Medical Doctor's Office General Hospital
425 W 113 St, New York, NY 10025
Sami A. Hashim
Sami Hashim MD
Internist
1111 Amsterdam Ave, New York, NY 10025
(212) 523-4163

Publications

Us Patents

Glyceride Esters For The Treatment Of Diseases Associated With Reduced Neuronal Metabolism Of Glucose

View page
US Patent:
20090197952, Aug 6, 2009
Filed:
Jun 29, 2007
Appl. No.:
12/304341
Inventors:
Sami A. Hashim - Dobbs Ferry NY, US
Joanna Jusis - Lincoln Park NJ, US
Jenifer Heydinger Galante - Oakland NJ, US
Joseph C. Rongione - Middletown NJ, US
International Classification:
A61K 31/22
A61K 31/23
A61P 25/28
A61P 25/08
A61P 25/16
US Classification:
514552, 514546
Abstract:
Provided are alternative sources of ketone bodies for reducing or eliminating symptoms of Parkinson's disease, amyotrophic lateral sclerosis (ALS, also called Lou Gehrig's disease), Alzheimer's disease, Huntington's disease, epilepsy and other diseases or disorders characterized by impaired glucose metabolism. The alternative sources of ketone bodies include mono-, di- and triglyceride esters of acetoacetate and mixtures thereof, and/or mono-, di- and triglyceride esters of 3-hydroxybutyrate and mixtures thereof. These glyceride esters can be administered orally as a dietary supplement or in a nutritional composition.

Glyceryl Tris (Beta-Hydroxybutyrate) And Neuronal Transient Ischemic Attacks

View page
US Patent:
20220288006, Sep 15, 2022
Filed:
May 30, 2019
Appl. No.:
17/608350
Inventors:
- New York NY, US
SAMI HASHIM - Dobbs Ferry NY, US
Assignee:
NeuroEnergy Ventures, Inc. - New York NY
International Classification:
A61K 31/22
A61P 25/28
Abstract:
A method of use of Gylceryl Tris (Beta-hydroxybutyrate) in the minimization, reduction, or prevention of neuronal deficit and/or neuronal cell death with respect to follow-on neuronal transient ischemic attacks (NTIAs) in subjects who have had (or in subjects exhibiting symptomology of having had) at least one prior NTIA.

Glyceryl 3-Hydroxybutyrates For Traumatic Brain Injury

View page
US Patent:
20200297686, Sep 24, 2020
Filed:
Jun 10, 2020
Appl. No.:
16/897349
Inventors:
- New York NY, US
Sami Hashim - Dobbs Ferry NY, US
Assignee:
NeuroEnerygy Ventures, Inc. - New York NY
International Classification:
A61K 31/225
Abstract:
A method of treatment of mild to moderate non-penetrating closed traumatic brain injury and mild to moderate TBI due to surgical intervention using 3-hydroxybutyate glycerides is disclosed.

Glyceryl 3-Hydroxybutyrates For Traumatic Brain Injury

View page
US Patent:
20180193300, Jul 12, 2018
Filed:
Mar 1, 2018
Appl. No.:
15/909240
Inventors:
- New York NY, US
Sami Hashim - Dobbs Ferry NY, US
Assignee:
NeuroEnergy Ventures, Inc. - New York NY
International Classification:
A61K 31/225
Abstract:
A method of treatment of mild to moderate non-penetrating closed traumatic brain injury and mild to moderate TBI due to surgical intervention using 3-hydroxybutyate glycerides is disclosed.

Glyceryl 3-Hydroxybutyrates For Migraine Symptom Management

View page
US Patent:
20180177753, Jun 28, 2018
Filed:
Dec 23, 2016
Appl. No.:
15/389828
Inventors:
- New York NY, US
Sami Hashim - Dobbs Ferry NY, US
Assignee:
NeuroEnergy Ventures, Inc. - New York NY
International Classification:
A61K 31/225
Abstract:
A method of management of migraine symptom reduction and/or management and/or prophylaxis is disclosed using 3-hydroxybutyate glycerides is disclosed.
Sami A Hashim from Dobbs Ferry, NY, age ~95 Get Report